Showing results (221-230 of 3,695) with videos related to

Sort By:
Pageof 370
International Journal of Clinical Oncology|March 13, 2017
Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumorsKota Arima, Hirohisa Okabe, Daisuke Hashimoto, et al.
International Journal of Clinical Oncology|March 27, 2017
The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysisDing Ye, Danjie Jiang, Yingjun Li, et al.
International Journal of Clinical Oncology|April 29, 2014
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomyTakuya Koie, Koji Mitsuzuka, Takahiro Yoneyama, et al.
International Journal of Clinical Oncology|March 18, 2014
A statistical study on malignant melanoma over the past 12 years in Fukui University HospitalMasato Yasuta, Suguru Sato, Sachio Kouraba, et al.
International Journal of Clinical Oncology|March 21, 2014
Salvage chemotherapy with gemcitabine plus oxaliplatin for patients with testicular germ cell cancerMasahiro Uchida, Koji Kawai, Tomokazu Kimura, et al.
International Journal of Clinical Oncology|March 26, 2014
Update of molecular pathobiology in oral cancer: a reviewTomonori Sasahira, Tadaaki Kirita, Hiroki Kuniyasu
International Journal of Clinical Oncology|March 26, 2014
Clinical features of long-term survivors of recurrent epithelial ovarian cancerHaruko Iwase, Toshio Takada, Chiaki Iitsuka, et al.
International Journal of Clinical Oncology|January 9, 2017
Review and proposal of regional surgical management for melanoma: revisiting of integumentectomy and incontinuity dissection in treatment of skin melanomaToshihiko Hayashi, Hiroshi Furukawa, Takashi Kitamura, et al.
International Journal of Clinical Oncology|January 9, 2017
Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinomaTakashi Suzuki, Hideaki Shimada, Tatsuki Nanami, et al.
International Journal of Clinical Oncology|January 13, 2017
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancerTakeshi Suto, Megumi Ishiguro, Chikuma Hamada, et al.
Pageof 370